Skip to main content
mSphere logoLink to mSphere
. 2023 Jun 5;8(4):e00587-22. doi: 10.1128/msphere.00587-22

Rhoptry neck protein 4 plays important roles during Plasmodium sporozoite infection of the mammalian liver

Minami Baba 1,2, Mamoru Nozaki 1, Mayumi Tachibana 1, Takafumi Tsuboi 3, Motomi Torii 1, Tomoko Ishino 1,4,✉
Editor: Laura A Kirkman5
PMCID: PMC10449513  PMID: 37272704

ABSTRACT

During invasion, Plasmodium parasites secrete proteins from rhoptry and microneme apical end organelles, which have crucial roles in attaching to and invading target cells. A sporozoite stage-specific gene silencing system revealed that rhoptry neck protein 2 (RON2), RON4, and RON5 are important for sporozoite invasion of mosquito salivary glands. Here, we further investigated the roles of RON4 during sporozoite infection of the liver in vivo. Following intravenous inoculation of RON4-knockdown sporozoites into mice, we demonstrated that sporozoite RON4 has multiple functions during sporozoite traversal of sinusoidal cells and infection of hepatocytes. In vitro infection experiments using a hepatoma cell line revealed that secreted RON4 is involved in sporozoite adhesion to hepatocytes and has an important role in the early steps of hepatocyte infection. In addition, in vitro motility assays indicated that RON4 is required for sporozoite attachment to the substrate and the onset of migration. These findings indicate that RON4 is crucial for sporozoite migration toward and invasion of hepatocytes via attachment ability and motility.

IMPORTANCE

Malarial parasite transmission to mammals is established when sporozoites are inoculated by mosquitoes and migrate through the bloodstream to infect hepatocytes. Many aspects of the molecular mechanisms underpinning migration and cellular invasion remain largely unelucidated. By applying a sporozoite stage-specific gene silencing system in the rodent malarial parasite, Plasmodium berghei, we demonstrated that rhoptry neck protein 4 (RON4) is crucial for sporozoite infection of the liver in vivo. Combined with in vitro investigations, it was revealed that RON4 functions during a crossing of the sinusoidal cell layer and invading hepatocytes, at an early stage of liver infection, by mediating the sporozoite capacity for adhesion and the onset of motility. Since RON4 is also expressed in Plasmodium merozoites and Toxoplasma tachyzoites, our findings contribute to understanding the conserved invasion mechanisms of Apicomplexa parasites.

KEYWORDS: malaria, Plasmodium, sporozoite, rhoptry, invasion

INTRODUCTION

Plasmodium parasites are in the phylum Apicomplexa and are the causative agents of malaria, a devastating infectious disease transmitted via mosquitoes. Approximately 600,000 people worldwide die from malaria each year (1). The life cycle of the Plasmodium parasite includes forms infectious for intracellular development, and one of which, the merozoite, mediates invasion and subsequent proliferation within erythrocytes. This erythrocytic infection cycle causes clinical symptoms such as anemia and fever. The sporozoite is the second such infective form and is transmitted from a vector mosquito to a mammalian host and ultimately invades hepatocytes.

To make a successful infection of host cells, apicomplexan parasites utilize a common structural organization at their anterior pole, called the apical complex (2, 3), which includes secretory organelles termed rhoptries and micronemes. Some secretory proteins stored in rhoptries are conserved among infectious forms of apicomplexan parasites, such as Plasmodium merozoites and Toxoplasma tachyzoites, and have roles during target cell invasion (4). For example, during merozoite invasion of erythrocytes, rhoptry neck protein (RON) 2, RON4, and RON5 are secreted to the host cell membrane to form the RON complex, which interacts with AMA1 on the parasite membrane to create a moving junction (5 - 9). The importance of the interaction between RON2 and AMA1 for merozoite invasion of erythrocytes has been shown using inhibitory antibodies and peptides (10 - 13). The inability to target gene disruption of ron2, ron4, ron5, or ama1 supports that these genes are crucial for merozoite invasion (14).

Sporozoites are formed in oocysts located between the epithelium and basal lamina of the mosquito midgut. After release into the hemolymph, sporozoites adhere to and invade salivary glands prior to transmission to mammalian hosts. Sporozoites are deposited into the skin during mosquito probing, and then actively migrate through the skin to enter blood vessels (15, 16). During passage through the liver, sporozoites recognize and traverse the sinusoidal cell layer to reach target hepatocytes (17, 18). Thus, sporozoites have a mechanism to migrate toward hepatocytes through different types of cells, in addition to infecting and differentiating within hepatocytes.

Both sporozoites and merozoites contain rhoptries at the apical end, in which proteins such as RON2, RON4, and RON5 are expressed (19). To elucidate the roles of RON2, RON4, and RON5 in sporozoites, we developed a sporozoite stage-specific knockdown system using the promoter swapping method (20). Repression of RON2, RON4, or RON5 expression in sporozoites demonstrated that the proteins are crucial for sporozoite invasion of salivary glands (20, 21). The importance of RON2 and RON4 in sporozoite invasion of salivary glands was confirmed by a conditional knockout system based on DiCre recombinase (22). These results raised the question of whether conserved rhoptry proteins are also required for sporozoite transmission from mosquitoes to mammals, specifically, migration toward and infection of hepatocytes.

Following the sporozoite invasion of hepatocytes, the parasites differentiate into liver stages (LS) and mature to form several thousand liver merozoites within a parasitophorous vacuole membrane (PVM). Risco-Castillo et al. reported that RON2 and RON4 are discharged during sporozoite invasion of hepatocytes (23), suggesting their importance for hepatocyte infection. By applying a promoter swapping strategy, we demonstrated that RON2 is involved in infection of the liver in vivo, as well as in infection of hepatocytes in vitro (20). In the case of RON4, only in vitro experiments were performed, using a conditional mutant parasite prepared by the FLP-FRT (flippase/flippase recombination target site) recombination system or DiCre recombinase and suggested that RON4 is involved in the infection of hepatocytes (24). However, the physiological roles of RON4 in sporozoite transmission to the liver remain unclear in vivo, including a potential role in migration toward hepatocytes.

In this study, the detailed functions of RON4 in sporozoite transmission to the liver were analyzed in vivo and in vitro using RON4 conditional knockdown (RON4-cKD) sporozoites, in which RON4 protein expression was suppressed to undetectable levels. The results revealed that RON4 has multiple roles during the sporozoite crossing of sinusoidal cells to arrive at hepatocytes, the adhesion of hepatocytes, and the invasion of hepatocytes, all of which are essential steps for sporozoite transmission from the mosquito to the mammalian liver.

MATERIALS AND METHODS

Parasites and mosquitoes

In this study, a transgenic Plasmodium berghei (Pb) ANKA parasite line (PbANKA-GFP) was used which constitutively expresses green fluorescent protein (GFP) under the control of the elongation factor 1A (ef1α) promoter without a drug resistance gene (25), kindly given by Dr. Janse. Transgenic Pb parasites in which the native ron4 promoter region was replaced by a promoter region for pb merozoite surface protein 9 (pbmsp9) or native pbron4, with a drug resistance cassette (named RON4-cKD and RON4-cont, respectively) were generated as described (21).

Cryopreserved PbANKA-infected erythrocytes were intraperitoneally injected into female ICR mice (4, 6 weeks old; CLEA Japan, Tokyo, Japan) to obtain blood-stage parasites. Anopheles stephensi SDA 500 strain mosquitoes were maintained on a 5% sucrose solution at 25°C. After feeding on Pb-infected ICR mice, fully engorged mosquitoes were selected and kept at 20°C under a 12-hour light/12-hour dark cycle until dissection. All animal experimental protocols were approved by the Institutional Animal Care and Use Committee of Ehime University and Tokyo Medical and Dental Univerity, and the experiments were conducted according to the Ethical Guidelines for Animal Experiments of Ehime University and Tokyo Medical and Dental University.

Generation of mCherry-tagged RON4 expressing transgenic parasites

To generate transgenic parasites expressing mCherry-tagged RON4 at its C-terminus, the native ron4 locus in the PbANKA-GFP genome was replaced by a single crossover homologous recombination with an expression cassette of the C-terminus of the ron4 coding region fused with an mCherry tag, similar to the generation of RON4-c-Myc expressing parasites (19). A schematic representation of the transgenic vector construction is shown in Fig. S1A. The c-Myc tag sequence was replaced by the mCherry tag sequence in the pL0033 plasmid (BEI Resources, Manassas, VA, USA), and then 1,626 base pairs corresponding to the RON4 C-terminus region, containing an XbaI site in the middle introduced by site-directed mutagenesis as described (19), was inserted at SacII and BamHI sites just upstream of the mCherry-tag coding region. Electroporation of 10–15 µg linearized DNA by XbaI digestion into a schizont-enriched PbANKA-GFP line and selection of transgenic parasites was performed as described (26). DNA integration occurs at the target locus in the PbANKA-GFP genome by single crossover homologous recombination as illustrated in Fig. S1A. Correct DNA integration into the target locus was confirmed by PCR genotyping, and transgenic parasites were cloned by limiting dilution.

Western blotting analysis

Sporozoites collected from the midguts of infected mosquitoes at days 18 to 21 post-feeding were purified by density gradient centrifugation using a 17% Accudenz solution (Accurate Chemical & Scientific Corporation, NY, USA) (27). Sporozoite pellets were resuspended and sonicated in a sample buffer solution for SDS-PAGE (nacalai tesque, Kyoto, Japan) containing 5% 2-mercaptoethanol. Sporozoites collected from salivary glands were directly resuspended in a sample buffer for SDS-PAGE. Proteins were separated by SDS-PAGE using 12.5% acrylamide gels (ATTO, Tokyo, Japan) and electroblotted onto polyvinylidene difluoride (PVDF) membranes. The PVDF membranes were blocked with Blocking One (nacalai tesque) for 1 hour at room temperature and then incubated overnight at 4°C with primary antibodies (1:500 anti-mCherry rabbit polyclonal antibodies [abcam, Cambridge, UK]; specifically, 1:1,000 anti-RON4 [21] or 1:20,000 anti-Heat Shock Protein 70 [HSP70] rabbit polyclonal antibodies [20]) diluted in phosphate-buffered saline (PBS) containing 1% skim milk (Megmilk Snow Brand, Tokyo, Japan). After washing with PBS containing 0.01% Tween-20 (PBST), the membranes were incubated with anti-rabbit IgG secondary antibodies conjugated to horseradish peroxidase (HRP; 1:30,000; Biosource, Camarillo, CA, USA) for 30 minutes at room temperature. Chemiluminescence detection was performed by adding Immobilon Western Chemiluminescent HRP Substrate (Merck Millipore, Darmstadt, Germany), and the signal was detected using an ImageQuant LAS 4010 (GE Healthcare, Chalfont St Giles, UK).

Confocal microscopy observation of sporozoites and liver-stage parasites

To investigate the expression pattern of RON4 in LS parasites, RON4-mCherry sporozoites were collected from salivary glands at days 25 to 28 post-feeding. Then, 80,000– 150,000 sporozoites were inoculated onto confluently seeded HepG2 cells, a human hepatoma cell line, in an eight-well chamber slide; then incubated in culture medium (RPMI 1640 medium [FUJIFILM Wako Pure Chemical, Osaka, Japan] containing 10% fetal calf serum [FCS], 100 IU/mL penicillin, and 100 µg/mL streptomycin [FUJIFILM Wako]) at 37°C in the presence of 5% CO2 for 24, 48, or 72 hours prior to observation. The RON4-mCherry sporozoites were also sowed directly onto glass bottom dishes just before observation. To detect nuclei, samples were stained with Hoechst 33342 (Sigma-Aldrich, St. Louis, USA) and observed using a confocal scanning laser microscope (LSM710; Carl Zeiss MicroImaging, Oberkochen, Germany).

Real-time reverse transcription (RT)-PCR

To confirm the transcript levels of ron4 in LS parasites, real-time RT-PCR was carried out using specific primers as shown in Table S1. Five or ten thousand sporozoites were collected from the salivary glands of PbANKA-GFP-infected mosquitoes at days 21 to 24 post-feeding and were injected intravenously into female C57BL/6 mice (CLEA Japan). For total RNA extraction, 24, 40, or 48 hours post-inoculation the livers were perfused and homogenized in 5 mL of Trizol (Thermo Fisher Scientific, San Jose, CA, USA) using a polytron homogenizer (Kinematica AG, Luzern, Switzerland). As a control, the infected mosquito salivary glands at day 17 post-feeding were collected in RNAlater (Thermo Fisher Scientific) and stored at 4°C until RNA isolation. Total RNA was extracted from infected mosquito salivary glands using an RNeasy Micro Kit (Qiagen GmbH, Hilden, Germany). After DNase treatment, cDNA was synthesized using a PrimeScript RT reagent Kit (Perfect Real Time; Takara Bio, Otsu, Japan). Real-time PCR was performed using a TaKaRa PCR Thermal Cycler Dice (Takara Bio) with an SYBR Premix Ex Taq (Takara Bio) and ron4-specific primers (Table S1; PbRON4 RT-F and R). Relative gene expressions were normalized by ef1α (PBANKA_1133300; Table S1; PbEF1a RT-F and R) mRNA levels and were compared using the comparative Ct method (19, 20, 28).

Indirect immunofluorescence assay (IFA)

Sporozoites were collected from salivary glands at days 19 to 22 post-feeding and seeded on eight-well multi-well slides, then air-dried and fixed with cold acetone for 3 minutes. The slides were blocked with Blocking One Histo (nacalai tesque) at 37°C for 30 minutes and incubated with primary antibodies (1:2,000 for anti-RON4 rabbit polyclonal antibodies, and anti-circumsporozoite protein (CSP) mouse monoclonal antibodies; MRA-100, obtained through BEI Resources, NIAID, NIH) in PBST containing 5% Blocking One Histo at 37°C for 2 hours, followed by Alexa Fluor 488–conjugated goat anti-rabbit IgG and Alexa Fluor 546–conjugated goat anti-mouse IgG (1:500, Thermo Fisher Scientific) at 37°C for 30 minutes. Nuclei were stained with 2 µg/mL of 4′,6-diamidino-2-phenylindole (DAPI). The samples were mounted in ProLong Gold antifade reagent (Thermo Fisher Scientific) and observed with an inverted fluorescence microscope (Axio Observer Z1; Carl Zeiss, Oberkochen, Germany).

In vivo liver infectivity

In vivo liver infectivity was performed as described (20). Briefly, 30,000 sporozoites were collected from salivary glands at days 20 to 23 post-feeding and injected intravenously into a female C57BL/6 mouse (CLEA Japan). One or 42 hours post-inoculation, the livers were perfused and homogenized in 5 mL of Trizol for total RNA extraction, followed by real-time RT-PCR analysis as described above (see the section “Real-time reverse transcription (RT)-PCR”). Experiments were performed using RON4-cont, independent knockdown clones: RON4-cKD cl1 and cl2, with 5 or 10 mice for each parasite line. The difference in the relative Pb18S rRNA levels between RON4-cont and RON4-cKD, after normalization using murine gapdh mRNA amounts, was analyzed by the Mann–Whitney U test. The primers used in these experiments are listed in Table S1 (Pb18S rRNA RT-F and R, MmGAPDH RT-F and R).

Determination of blood-stage parasitemia after sporozoite inoculation

Sporozoites were collected from salivary glands at days 19 to 21 post-feeding and injected intravenously into female C57BL/6 mice (CLEA Japan). The parasitemias of infected mice were monitored by daily blood smears from days 3 to 7 post-infection. Blood smears were stained in Giemsa solution, and infected erythrocytes were counted using a light microscope.

In vitro sporozoite cell traversal assay

Cell traversal ability was assayed by the number of wounded cells 1 hour after sporozoite inoculation as described (29). Briefly, 10,000 hemocoel sporozoites were incubated for 1 hour on confluent 3T3-Swiss albino cells in an eight-well chamber slide, with 2 mg/mL fluorescein-conjugated dextran (molecular weight 10,000, lysine fixable; Thermo Fisher Scientific) in RPMI 1640 medium containing 10% FCS. Cells were washed with PBS and fixed with 10% formalin. Fluorescence-labeled cells were counted under a fluorescence microscope (Axio Observer Z1). Experiments were repeated five times with more than three wells for each parasite line.

In vitro sporozoite invasion analyses

The numbers of extracellular and intracellular sporozoites of HepG2 cells were examined by an invasion assay using two kinds of anti-CSP antibodies (30, 31). To distinguish between extracellular and intracellular sporozoites, 10,000 sporozoites from RON4-cont, RON4-cKD cl1, and RON4-cKD cl2 lines were collected from salivary glands at days 16 to 23 post-feeding and inoculated onto HepG2 with culture medium in eight-well chamber slides. After adding sporozoites, slides were centrifuged at 500 × g for 5 minutes at room temperature and incubated for 1 hour at 37°C with 5% CO2. Cells were fixed with 10% formalin. The slides were blocked with 10% FCS at 37°C for 30 minutes and extracellular sporozoites were labeled with anti-rabbit CSP-repeat region antibodies, followed by Alexa Fluor 546–conjugated goat anti-rabbit IgG antibodies (1:500). The cells were then permeabilized with 0.1% Triton X-100 and re-labeled using anti-CSP mouse monoclonal antibodies followed by Alexa Fluor 488–conjugated goat anti-mouse IgG antibodies (1:500). The numbers of extracellular and intracellular sporozoites were examined by quantification of double- or single-stained sporozoites under a fluorescence microscope (Axio Observer Z1). Experiments were repeated four times with more than three wells for each parasite line.

For infection assays, five thousand sporozoites from the RON4-cont, RON4-cKD cl1, and RON4-cKD cl2 lines were collected from salivary glands at days 16 to 23 post-feeding and were inoculated onto HepG2 cells as described above and incubated for 6 or 48 hours at 37°C with 5% CO2. Cells were fixed with 10% formalin and permeabilized by 0.1% Triton X-100. The slides were blocked with 10% FCS at 37°C for 30 minutes and incubated with primary antibodies (1:500 for anti-upregulated in infective sporozoites 4 (UIS4) rabbit polyclonal antibodies, and anti-CSP mouse monoclonal antibodies) in PBS containing 10% FCS at 37°C for 2 hours, followed by Alexa Fluor 546–conjugated goat anti-rabbit IgG and Alexa Fluor 488–conjugated goat anti-mouse IgG at 37°C for 30 minutes. Nuclei were stained with 2 µg/mL of DAPI. The number of infected sporozoites (6 hours) and LS parasites (48 hours) were counted. Experiments were repeated five times with more than three wells for each parasite line.

In vitro sporozoite attachment and motility assay

RON4-cont, RON4-cKD cl1, and RON4-cKD cl2 sporozoites were collected from salivary glands at days 19 to 26 post-feeding. For attachment and motility assays on glass slides, sporozoites in RPMI 1640 medium containing 10% FCS were placed in a glass-bottom dish. For gliding assays in Matrigel, sporozoites in RPMI 1640 containing 20% FCS were mixed with an equal volume of Matrigel (Corning, NY, USA) and placed on glass bottom dishes. Sporozoite movement was detected by GFP fluorescence using an Axio Observer Z1 and recorded with an AxioCam MRm charge-coupled device camera (Carl Zeiss) every 2 seconds for up to 150 frames (5 minutes). Sporozoites on glass slides were classified manually according to their attachment patterns as follows: full-length-attached, partial-attached, or non-attached. Full-length-attached sporozoites were further categorized depending on their motility. Experiments were repeated five times with at least 80 sporozoites per parasite line. The effect of RON4 repression on sporozoite attachment and motility was evaluated by comparison with RON4-cont sporozoites. In Matrigel, sporozoites were categorized as moving in a circular mode (circulating), meandering, or non-motile, according to the work of Nozaki et al. (21). Experiments were repeated four times with at least 40 sporozoites for each line. The velocity of gliding sporozoites was calculated using the MTrack2 plugin in Fiji software (https://imagej.net/plugins/mtrack2).

RON4 discharge during sporozoite migration

To investigate the discharge of RON4 protein from sporozoites during migration, RON4-cont sporozoites collected from salivary glands on day 21 post-feeding were suspended in RPMI 1640 containing 10% FCS and transferred to eight-well chamber slides. After adding sporozoites, slides were centrifuged at 500×g for 5 minutes at room temperature and incubated for 1 hour at 37°C with 5% CO2. Slides were washed with PBS and fixed with 2% paraformaldehyde. The slides were blocked with Blocking One Histo at 37°C for 30 minutes and incubated with primary antibodies (1:2,000 for anti-RON4 rabbit polyclonal antibodies, and anti-CSP mouse monoclonal antibodies) in PBS containing 5% Blocking One Histo at 37°C for 2 hours, followed by Alexa Fluor 488–conjugated goat anti-rabbit IgG (1:500) and Alexa Fluor 546–conjugated goat anti-mouse IgG (1:500) at 37°C for 30 minutes. Nuclei were stained with Hoechst 33342 (1:500).

Antibody inhibition against sporozoite invasion of hepatocytes

To investigate the effects of anti-RON4 antibodies during sporozoite invasion of hepatocytes, 20,000 or 30,000 PbANKA-GFP sporozoites were collected from salivary glands at days 20 to 28 post-feeding and inoculated onto HepG2 cells with medium containing anti-RON4 or anti-glutathione S-transferase (GST) rabbit IgG at 62.5 µg/mL, 125 µg/mL, 250 µg/mL, 500 µg/mL, or 1 mg/mL and incubated for 1.5 hours in culture medium in an eight-well chamber slide. For IgG purification, antiserum against RON4 or GST was applied to protein G columns (GE Healthcare, NJ, USA) according to the manufacturer’s instructions. As a negative control, PBS was added instead of IgG. The cells were washed with the culture medium three times and further incubated for 4.5 hours with the culture medium at 37°C with 5% CO2. After a total of 6 hours of incubation, cells were washed with PBS and fixed with 10% formalin and permeabilized by 0.1% Triton X-100. The parasites were detected by IFA using antibodies against UIS4 and CSP as described above. The number of infected parasites identified as PVM-positive was counted. Experiments were repeated four times with three wells for Fig. 6 and twice with two wells for the antibody dose dependency in Fig. S9.

Fig 6.

Fig 6

Antibodies against RON4-suppressed sporozoite infection of hepatocytes. Twenty thousand PbANKA-GFP sporozoites were collected from salivary glands and were inoculated onto HepG2 cells cultured in an eight-well chamber slide. The cells were incubated for 1.5 hours with 1 mg/mL of anti-RON4 antibody, anti-GST antibody, or PBS included in the culture medium. After 6 hours of incubation, the cells were washed with PBS, fixed with 10% formalin, and permeabilized by 0.1% Triton X-100. The parasites were detected by immunofluorescence using antibodies against UIS4 and CSP. The mean values of PVM-positive parasites are shown as bars with SD as error bars, from four experiments with three wells for each antibody treatment. The statistical difference was calculated by one-way ANOVA followed by Dunnett’s multiple comparison test (***P < 0.001, ns: no statistical difference).

Statistical analysis

All statistical analyses were performed using Prism 9 software (GraphPad, version 9. 3. 1 [350]). All data were checked for normality and homogeneity of variance to analyze accordingly using parametric or non-parametric test. Mann–Whitney U test was used for comparisons between the two groups. One-way analysis of variance (ANOVA), Brown–Forsythe test, or Kruskal–Wallis test were performed to compare more than three groups. Dunnett’s multiple comparison test was used as the post hoc for parametric tests, and Dunn’s post hoc test was used as the post hoc for non-parametric tests. Statistical significance was set at P < 0.05.

RESULTS

RON4 expression pattern in sporozoites and liver-stage parasites

RON4 is expressed and localized to rhoptries in both merozoites and sporozoites of Plasmodium berghei (19). To investigate RON4 contribution to parasite transmission from mosquitoes to mammals, the RON4 expression pattern was examined in the LS by generating a transgenic P. berghei ANKA parasite line which expresses mCherry-tagged RON4 instead of the RON4 native coding sequence (RON4-mCherry; see the section “Materials and Methods” and Fig. S1A). The successful expression of mCherry-tagged RON4 in oocyst-derived sporozoites was demonstrated by western blot using anti-RON4 and anti-mCherry antibody staining (Fig. S1B). Two bands corresponding to full-length RON4 (about 100 kDa) and a processed form (about 60 kDa) were observed on western blots, both of which were shifted due to the successful addition of an mCherry-tag at the C-terminus. Inoculating sporozoites collected from mosquito salivary glands to C57BL/6 mice demonstrated that RON4-mCherry-expressing sporozoites could normally infect and proliferate within hepatocytes (Fig. S1C). By confocal fluorescence microscopy, RON4-mCherry signals were confirmed to localize at the apical end of sporozoites residing in salivary glands, consistent with a rhoptry localization (Fig. 1, top row) (21). To examine RON4-mCherry expression in LS parasites, RON4-mCherry sporozoites collected from salivary glands were inoculated onto the human hepatoma cell line, HepG2. At 24 and 48 hours post-inoculation, RON4-mCherry signals were undetectable in LS parasites (Fig. 1, second and third rows). At 72-hour post-inoculation, RON4-mCherry signals were detected as dots corresponding to the tip of mature liver merozoites (Fig. 1, bottom row).

Fig 1.

Fig 1

RON4 expression pattern in sporozoites and liver-stage (LS) parasites. Expression of RON4-mCherry in sporozoites and liver-stage parasites. RON4-mCherry sporozoites were collected from salivary glands at days 25 to 28 post-feeding. The sporozoites were inoculated on HepG2 cells in culture medium in glass bottom dishes and then incubated for 24 hours (LS 24 h), 48 hours (LS 48 h), and 72 hours (LS 72 h). Sporozoites were also inoculated on a glass bottom dish without cells (sporozoites). Live parasites were detected by cytosol GFP signal (green). RON4 was detected by an mCherry signal (magenta). Nuclei were stained with Hoechst 33342 (blue). Scale bars, 5 µm. The inserted image demonstrates an enlarged liver merozoite (scale bar, 1 µm).

Next, the ron4 mRNA expression pattern during LS parasite development was measured in vivo, by intravenous inoculation of PbANKA-GFP sporozoites into C57BL/6 mice. The relative ron4 mRNA amounts in sporozoites and in LS parasites were examined by real-time RT-PCR at 24, 40, and 48 hours post-sporozoite inoculation and normalized by Plasmodium ef1α mRNA expression. While ron4 mRNA transcription was clearly detected in sporozoites collected from salivary glands, as reported (19), ron4 mRNA was undetectable in LS parasites at 24 and 40 hours after sporozoite inoculation (Fig. S2; LS 24 h and LS 40 h). Ron4 mRNA became detectable at the late LS, 48 hours after sporozoite inoculation (Fig. S2; LS 48 h), a timepoint at which merozomes, infected hepatocytes filled with matured merozoites, begin sequestration into blood vessels to release merozoites (32). These data demonstrated that ron4 transcription is upregulated significantly on hepatic-merozoite maturation, which is consistent with protein detection results (Fig. 1). Since ron4 transcription in the LS is repressed until hepatic merozoites are mature, RON4 is unlikely to be required for parasite proliferation in hepatocytes. Therefore, we further investigated the role of RON4 in sporozoites in terms of mosquito-to-mammal transmission.

RON4 is required for sporozoite infection of the liver

To investigate RON4 roles during sporozoite infection of the liver, sporozoite stage-specific ron4 knockdown (RON4-cKD) P. berghei ANKA parasites were used, which were previously generated by replacing the native ron4 promoter with a merozoite surface protein 9 promoter (21). RON4-cKD oocyst-derived sporozoites repress ron4 transcription to levels approximately 70-fold less than PbANKA-GFP and result in a roughly 30-fold lower ability to invade salivary glands (21). To determine whether the small number of RON4-cKD sporozoites that successfully invade salivary glands is due to the leaky expression of RON4, an IFA was performed on RON4-cKD sporozoites collected from salivary glands. As shown in Fig. 2, the specific signal corresponding to RON4 detected at the apical end of RON4-cont sporozoites could not be detected in RON4-cKD sporozoites. The decrease in RON4 protein amount was confirmed by Western blotting (Fig. S3). Therefore, we used RON4-cKD sporozoites collected from salivary glands for further experiments to investigate RON4 involvement in sporozoite infection of mammalian livers.

Fig 2.

Fig 2

RON4 signal is undetectable in sporozoite stage-specific ron4 knockdown parasites collected from salivary glands. Indirect immunofluorescence analysis of RON4. Sporozoites collected from salivary glands were stained with anti-RON4 and anti-CSP antibodies with nuclei visualized with 4’,6-diamidino-2-indole (DAPI). The individual signals are shown in black and white. Merged images in the right columns contain RON4 (shown in green), CSP (purple), and DAPI (blue). In RON4-cont sporozoites, the specific signals corresponding to RON4 were detected at the apical end; however, these signals were undetectable at the apical end (arrowheads) of RON4-cKD sporozoites. Bar, 5 µm.

At first, we clarified whether RON4 is required for sporozoite infection of the C57BL/6 mouse liver in vivo by intravenous injection of RON4-cont or two independent clones of RON4-cKD (cl1 and cl2) sporozoites collected from salivary glands. The relative P. berghei 18S ribosomal RNA (Pb18S rRNA) levels in the liver at 42 hours after sporozoite inoculation, when most hepatic merozoites are formed but remain inside cells, were approximately 23-fold and 14-fold lower for RON4-cKD cl1 and RON4-cKD cl2, respectively, compared to that of livers inoculated with RON4-cont sporozoites (Fig. 3A and Fig. S4A) This result showed that RON4 has crucial roles during sporozoite infection of the liver in vivo.

Fig 3.

Fig 3

RON4 is required for sporozoite infection of the liver. Infectivity of RON4-repressed sporozoites in mice. Thirty thousand RON4-cont or RON4-cKD cl1 sporozoites were collected from salivary glands at days 20 to 23 post-feeding and were inoculated into C57BL/6 mice. Their livers were collected to measure parasite 18S rRNA levels 42 hours (A) or 1 hour (B) after inoculation. The relative parasite 18S rRNA levels were normalized to mouse gapdh mRNA level and are shown as dot plots. The median values of five mice (long line) are shown with the interquartile range as error bars (short bars). The statistical difference in the relative expression of Pb18S rRNA between RON4-cont and RON4-cKD cl1 was calculated by the Mann–Whitney U test (**P < 0.01, ****P < 0.0001).

Sporozoites in the bloodstream cross the sinusoidal cell layer to infect hepatocytes, which is completed within 1 hour after inoculation (33). To determine whether RON4 is required for sporozoite crossing the sinusoidal cell layer in vivo, sporozoite relative amounts in the liver after perfusion at 1-hour post-inoculation of 30,000 salivary gland–derived sporozoites were compared between RON4-cont and RON4-cKD by real-time RT-PCR. The relative Pb18S rRNA levels of RON4-cKD cl1 and RON4-cKD cl2 in the liver were approximately 4.0-fold and 4.5-fold less, respectively, than that of RON4-cont sporozoites (Fig. 3B and Fig. S4B). This result demonstrates that RON4 knockdown decreases sporozoite accumulation in the liver parenchyma, likely due to a compromised ability to cross the sinusoidal cell layer. In addition, no parasites reappeared in the C57BL/6 mouse blood after 2,000 RON4-cKD sporozoites were intravenously inoculated, while all mice were infected by inoculation of the same amount of RON4-cont sporozoites (Fig. S5). Taken together, RON4 is important for sporozoites to exit from the bloodstream, in addition to the infection of the liver.

RON4 is required for sporozoite cell traversal ability and hepatocyte invasion efficacy

It was reported that to cross the sinusoidal cell layer, sporozoites need to penetrate cells by wounding the cellular membrane, called cell traversal ability (29). To investigate the cell traversal ability of salivary gland sporozoites, we performed in vitro cell wounding assays by detecting dextran-fluorescein isothiocyanate-containing cells due to membrane damage by sporozoite penetration. The cell traversal ability of RON4-cKD cl1 and cl2 sporozoites, indicated by the number of wounded cells, was significantly reduced to 18% of RON4-cont parasites (Fig. 4A). These results confirmed that RON4 contributes to the sporozoite cell traversal ability, which is required for crossing the sinusoidal cell layer to arrive at the liver parenchyma.

Fig 4.

Fig 4

RON4 is required for sporozoite ability to traverse cells and invade hepatocytes. (A) The cell traversal ability of sporozoites was examined by a cell wounding assay using fluorescein-conjugated dextran. Ten thousand hemolymph sporozoites were collected from RON4-cont, RON4-cKD cl1, or RON4-cKD cl2 infected mosquitoes and inoculated onto 3T3 cells cultured confluently in eight-well chamber slides. Cells were incubated for 1 hour with 2 mg/mL of fluorescein-conjugated dextran (10,000 mol wt) in RPMI 1640 containing 10% FCS. The numbers of cells harboring dextran per well are shown as dot plots. The median values of five independent experiments (long line) are shown with the interquartile range as error bars (short bars). The statistical difference was calculated by Kruskal–Wallis followed by Dunn’s post hoc test (*P < 0.05, **P < 0.01). (B–H) The invasion ability of RON4-cKD sporozoites to HepG2 was examined in vitro. RON4-cont, RON4-cKD cl1, or RON4-cKD cl2 sporozoites (10,000 [B–D] or 5,000 [E–H]) were collected from salivary glands and inoculated onto HepG2 cells cultured in an eight-well chamber slide and then incubated for 1 hour (B–D), 6 hours (E–G), or 48 hours (H) at 37°C. The numbers of extracellular or intracellular sporozoites (C), intracellular sporozoites (D), adhered or invaded parasites (F), invaded parasites with PVM (G), and LS parasites (H) are shown as dot plots. The median (C, D, G, and H) or mean (F) values of five independent experiments (long line) are shown with the interquartile range (C, D, G, and H) or SD as error bars (F) (short bars). Experiments were repeated more than four times with more than three wells for each parasite line. The statistical difference was calculated by the Brown–Forsythe test followed by Dunnett’s post hoc test (C, G, and H), Kruskal–Wallis followed by Dunn’s post hoc test (D), or one-way ANOVA followed by Dunnett’s multiple comparison test (F). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. (B) Representative IFA images of adhered and invaded sporozoites at 1 hour after inoculation. Sporozoites were stained by anti-CSP antibodies pre- (purple) and post- (green) permeabilization of cells. Nuclei are visualized with DAPI in merged images (blue). An extracellular sporozoite is visualized by purple and green fluorescence (merged panel, left sporozoite), while an intracellular sporozoite is visualized only by green fluorescence (merged panel, right sporozoite). Bar, 5 µm. (E) The parasites were detected by immunofluorescence using antibodies against UIS4 (magenta, middle panel) and CSP (green, left panel). Nuclei are visualized with DAPI in merged images (blue, right panel). Bar, 5 µm.

To examine whether RON4 is involved in sporozoite invasion of hepatocytes, an in vitro sporozoite invasion assay was performed. One hour after sporozoite inoculation onto HepG2 cells, extracellular or intracellular sporozoites were distinguished by double staining using anti-CSP mouse and rabbit antibodies (30) (Fig. 4B). For RON4-cont parasites, greater than 18% of inoculated sporozoites were detected as adhered to or invaded HepG2 cells at 1-hour post-inoculation, and approximately half of them were located intracellularly (Fig. 4C and D; Table 1). For RON4-cKD cl1 and cl2, roughly 9% of inoculated sporozoites were detected extra- or intracellularly, demonstrating that their adhesion ability decreased to approximately half of the control. In addition, only 15% and 14% of these attached RON4-cKD cl1 and cl2 sporozoites invaded HepG2 cells, respectively, indicating that RON4 repression also reduces sporozoite invasion efficiency after adhesion of cells to about 30% of the control (Fig. 4C and D; Table 1). As a result, roughly 1% of inoculated RON4-cKD sporozoites successfully invaded hepatocytes, while 9% of RON4-cont sporozoites invaded cells (Fig. 4D and Table 1). These results indicate that RON4 is involved in sporozoite adhesion to and invasion of hepatocytes.

TABLE 1.

The number and percentage of extracellular or intracellular sporozoites 1 hour after inoculation

Inoculated Extra- or intracellular Intracellular Ratio of intracellular sporozoites/detected sporozoites (%)
Median (Min.–Max.) a ,
% inoculated b
% RON4-cont Median (Min.–Max.) a , % inoculated b % RON4-cont
RON4-cont 10,000 1,819 (1,308–2,147), 18.2% 100 909 (476–1,045), 9.1% 100 50
RON4-cKD cl1 10,000 887 (809–907), 8.9% 48.8 136 (82–220), 1.4% 15 15.3
RON4-cKD cl2 10,000 913 (730–1,011), 9.1% 50.2 131 (77–155), 1.3% 14.4 14.3
a

“Extra- or intracellular” and “Intracellular”: median, minimum, and maximum values in parentheses.

b

“Extra- or intracellular” and “Intracellular”: percentage of inoculated sporozoites.

To examine if the invaded sporozoites are surrounded by a PVM, sporozoite-inoculated HepG2 cells were stained with anti-UIS4 antibodies, a PVM marker, together with anti-CSP antibodies (Fig. 4E). The numbers of detected RON4-cKD sporozoites, which included both adhered and invaded sporozoites, were reduced to about 50% of that of the RON4-cont, which confirmed that RON4 repression decreased sporozoite attachment ability (Fig. 4F). Approximately 7% of RON4-cont inoculated parasites were surrounded by PVM, whereas 0.8% each of RON4-cKD cl1 and cl2 parasites were within PVM at 6 hours after sporozoite inoculation (Fig. 4G and Table 2). Taking into consideration that the ratios of RON4-cKD parasites surrounded by PVM compared to RON4-cont cl1 and cl2 were approximately 12% and 11%, which were comparable to the ratio of RON4-cKD invaded sporozoites at 1-hour post-inoculation, it indicated that the major RON4 function takes place at the early stage of hepatocyte infection, that is, adhesion to and invasion of hepatocytes (Table 1 and 2).

TABLE 2.

The number and percentage of adhered or invaded parasites 6 hours after inoculation

Inoculated Adhered or invaded Invaded (PVM positive)
Median (Min.–Max.) a ,
% inoculated b
% RON4-cont Median (Min.–Max.) a ,
% inoculated b
% RON4-cont
RON4-cont 10,000 1,445 (1,308–1,516), 14.5% 100 685 (476–802), 6.9% 100
RON4-cKD cl1 10,000 809 (477–966), 8.1% 56 82 (53–96), 0.8% 12
RON4-cKD cl2 10,000 629 (565–730), 6.3% 43.5 77 (66–94), 0.8% 11.2
a

“Adhered or invaded” and “Invaded”: median, minimum and maximum values in parentheses.

b

“Adhered or invaded” and “Invaded”: percentage of inoculated sporozoites.

TABLE 3.

The proportion of sporozoites showing each attachment and motility pattern (%)

Sporozoite attachment and motility pattern (%) Full-length-attached
and motility (+) a
Full-length-attached and
motility (−) a
Partial-attached a Non-attached a
RON4-cont 61.5 (50.8-80.3) 0.9 (0.0-2.3) 8.2 (0.3-22.9) 25.7 (11.6-35.0)
RON4-cKD cl1 9.2 (0-13.7) 14.9 (4.4-18.6) 22.7 (12.0-25.7) 55.2 (45.7-83.5)
RON4-cKD cl2 10.0 (1.7-13.4) 15.4 (8.7-23.5) 20.9 (14.8-35.0) 50.0 (43.6-72.6)
a

Median, minimum, and maximum values in parentheses.

The importance of RON4 during sporozoite infection of hepatocytes was further confirmed by continuous incubation until 48-hour post-sporozoite inoculation, a time at which LS parasites grow sufficiently to be easily detected by IFA using antibodies against CSP and UIS4 (34). The LS parasite numbers were decreased in RON4-cKD cl1 and cl2 parasites to approximately 19-fold and 15-fold less, respectively, compared to RON4-cont parasites (Fig. 4H). This result was consistent with a study using the Cre/LoxP-dependent gene excision conditional knockout system (24). The diameters of RON4-cKD LS parasites were comparable to those of RON4-cont (Fig. S6), indicating that RON4 is dispensable for LS development after sporozoites invade hepatocytes. Taken together, in vitro assays demonstrated that RON4 is crucial for both cell invasion pathways, specifically, traversing cells by membrane wounding and invading hepatocytes with PVM formation.

RON4 has important roles in sporozoite attachment and motility

The attachment ability and motility of sporozoites have been shown to be essential for the infection of the liver (20, 35 - 37). We have reported that RON4-cKD sporozoites collected from mosquito hemolymph show less attachment ability and motility than RON4-cont sporozoites, which results in less invasion efficiency to salivary glands (21). Here, we assessed the in vitro gliding ability of RON4-cKD sporozoites that had successfully invaded salivary glands. Sporozoites were incubated with FCS containing medium on glass slides and categorized depending on their attachment patterns as follows: full-length-attached, partial-attached, and non-attached (Fig. 5A). The population of full-length-attached sporozoites decreased in RON4-cKD cl1 and cl2 approximately three-fold compared with the RON4-cont (Fig. 5B; the median ratio was 64% in RON4-cont and 25% in RON4-cKD). Accordingly, the population of non-attached sporozoites increased in RON4-cKD cl1 and cl2 approximately two-fold compared with the RON4-cont (Fig. 5B; the median ratio was 26% in RON4-cont, 55% in RON4-cKD cl1, and 50% in RON4-cKD cl2). Taken together, RON4 is involved in the attachment ability of sporozoites residing in salivary glands, similar to sporozoites collected from the hemolymph.

Fig 5.

Fig 5

Comparison of sporozoite attachment and motility among transgenic parasite lines. The attachment and motility ability of sporozoites collected from salivary glands at days 19 to 26 post-feeding were examined in vitro. RON4-cont, RON4-cKD cl1 or cl2 sporozoites were inoculated onto a glass bottom dish (A–C) or embedded in Matrigel (D–F), then their movements were recorded every 2 seconds for about 5 minutes (up to 150 frames). (A) Time-lapse micrographs of each attachment pattern. Sporozoites were categorized as full-length-attached (upper panel), partial-attached (middle panel), and non-attached (lower panel). Full-length-attached sporozoites were further categorized depending on their motility. Bars, 5 µm. (B) Sporozoite attachment patterns were compared between RON4-cont and RON4-cKD sporozoites. Box plots demonstrate the percentage of sporozoites showing each attachment pattern with error bars indicating the minimum value and maximum value from five independent experiments containing at least 80 sporozoites per parasite line (red: RON4-cont, green: RON4-cKD cl1, blue: RON4-cKD cl2). The statistical difference in each attachment pattern was calculated by Kruskal–Wallis followed by Dunn’s post hoc test (*P < 0.05, **P < 0.01, ns: no statistical difference). (C) The percentage of motile sporozoites in full-length-attached sporozoites. Box plots demonstrate the percentage of gliding sporozoites with error bars indicating minimum value and maximum value. Experiments were repeated five times with at least 110 (RON4-cont) or 25 (RON4-cKD cl1 and cl2) sporozoites per parasite line. The statistical difference was calculated by Kruskal–Wallis followed by Dunn’s post hoc test (*P < 0.05). (D) Time-lapse micrographs of sporozoite motility patterns in Matrigel. Sporozoites were categorized as circulating (upper panel), meandering (middle panel), and non-motile (lower panel). Bars, 5 µm. (E) The box plots show the percentages of sporozoites showing each motility pattern with minimum and maximum values as error bars from four independent experiments with at least 40 sporozoites per parasite line (red: RON4-cont, green: RON4-cKD cl1, blue: RON4-cKD cl2). The statistical difference in each attachment pattern was calculated by Kruskal–Wallis followed by Dunn’s post hoc test (*P < 0.05). (F) The velocity of each circulating sporozoite (n > 19) was plotted. Sporozoite movement was traced using the MTrack2 plugin in Fiji software. No significant difference in the velocity was detected among RON4-cont, RON4-cKD cl1, and RON4-cKD cl2 examined by the Kruskal–Wallis test (P = 0.18).

Next, RON4 contributions to sporozoite motility were analyzed. Among full-length-attached sporozoites, over 95% of sporozoites in RON4-cont showed gliding motility versus 36% and 32% in RON4-cKD cl1 and cl2, respectively (Fig. 5C). As a result, the proportions of gliding sporozoites in inoculated sporozoites were 62% in RON4-cont, 9% in RON4-cKD cl1, and 10% in RON4-cKD cl2 (Table 3), indicating that RON4 is important for both attachments to the glass slide and motility.

To confirm whether RON4 is required for sporozoite motility as well as attachment ability, sporozoites were embedded in Matrigel, a matrix composed of laminin and type IV collagen, thus bypassing the adhesion step to the substrate. Sporozoite-moving patterns were analyzed by the categories described by Nozaki et al. (21), as follows: circulating, continuous migration through the Matrigel in a circular pattern; meandering, incompletely proceeding; and non-motile, not moving forward or staying immotile (Fig. 5D). When embedded in Matrigel, 81% of RON4-cont sporozoites circulated, whereas only 10% and 16% of RON4-cKD cl1 and cl2 sporozoites circulated, respectively (Fig. 5E). Accordingly, 74% and 66% of RON4-cKD cl1 and cl2 sporozoites did not move forward in the Matrigel, whereas 10% of RON4-cont sporozoites remained non-motile (Fig. 5E). On the other hand, the velocity of continuously moving sporozoites showed no significant difference between RON4-cont and RON4-cKD sporozoites (Fig. 5F). These results demonstrate that RON4 in salivary gland sporozoites has important roles both in attachment to substrates and in the initiation of movement; however, it is not essential for moving speed, which is mediated by an actomyosin system called the glideosome (38). Attachment is required during gliding, and thus the duration of attachment is also reduced by RON4 repression (Fig. S7).

Anti-RON4 antibody suppressed sporozoite invasion of hepatocytes

Next, we investigated whether RON4 is secreted during migration and invasion of cells, as reported for Plasmodium yoelii sporozoites (23). RON4 could be detected at the tips of sporozoites without permeabilization by incubation in FCS-containing medium to activate gliding (Fig. S8). To confirm RON4 secretion, we examined whether anti-RON4 antibodies inhibit sporozoite infection of hepatocytes. Sporozoites were isolated from salivary glands, and prior to inoculation HepG2 cells were incubated with antibodies against RON4 or GST as a negative control. The invaded parasites surrounded by PVM were reduced to approximately 30% of control by anti-RON4 antibody treatment (Fig. 6A), and inhibition of sporozoite invasion was in an antibody dose-dependent manner (Fig. S9). These results indicate that secreted RON4, which could be targeted by antibodies, functions during sporozoite infection of hepatocytes.

DISCUSSION

In this study, we have demonstrated in vivo that RON4 is important for Plasmodium sporozoite transmission from the mosquito to the mammalian liver, in addition to sporozoite invasion of mosquito salivary glands (21). Using RON4-cKD sporozoites generated by the promoter substitution method, we revealed that RON4 has important roles in cell traversal, which is required for migration through the sinusoidal cell layer to reach hepatocytes, and in hepatocyte invasion with PVM formation. After hepatocyte invasion, RON4 ceases expression and does not appear to be involved in LS parasite development or differentiation into liver merozoites.

These results confirmed studies that used conditional RON4-knockout sporozoites by inducible FLP-FRT recombination and DiCre excision systems, demonstrating that RON4 is required for hepatocyte infection in vitro (22, 24). Unlike these gene excision systems, in which a small portion of RON4 expressing sporozoites remained, our RON4-cKD sporozoites by promotor-swapping repressed RON4 uniformly (21). Therefore, in this study, we could use an in vivo infection model to address in detail further questions about the roles of RON4 during sporozoite infection of the liver.

Previously, we revealed that the RON complex components (RON2, RON4, and RON5) are involved in hemolymph sporozoite motility, which is required for sporozoite invasion of salivary glands (20, 21). Since motility is also known to be crucial for sporozoite transmission from mosquitoes to mammalian livers, we investigated the contribution of RON4 to these processes. This study revealed that RON4 in salivary gland sporozoites is important for attachment ability, which is crucial for multiple steps such as the initiation and continuation of sporozoite migration (Fig. 5B and C; Fig. S7). In addition, motility did not recover even after RON4-cKD sporozoites were embedded in Matrigel (Fig. 5E), revealing that RON4 is not only important for sporozoite attachment prior to gliding but also for the initiation of gliding. Considering a previous report demonstrating that the turnover of discrete adhesion sites is crucial for the continuous movement of sporozoites (39), RON4 is required for sporozoite migration via mediating adhesion ability.

Motility is essential for sporozoites deposited by the mosquito into the skin to migrate and infect hepatocytes in vivo (40) and is dependent on the secretion of microneme proteins, such as TRAP (41, 42). Studies on micronemal proteins demonstrated that mutant sporozoites with less attachment/gliding ability show decreased cell traversal ability (43 - 46), which is required for crossing the sinusoidal cell layer (29). Such a phenotype was observed for the TRAP-like protein (TLP) knockout, Plasmodium protein O-fucosyltransferase (POFUT2) knockout, and the Cell Traversal for Ookinetes and Sporozoites (S4/Celtos) knockdown. RON4-cKD sporozoites also showed phenotypes of both a decreased ability in cell traversal in vitro and in crossing the sinusoidal cell layer in vivo (Fig. 3B, Fig. 4A, and Fig. S4B), possibly due to reduced attachment and initiation of gliding. As discussed above, it seems reasonable that the traversal ability of sporozoites depends on their attachment ability, because continuous migration requires the turnover of adhesive sites. However, further confirmation is necessary; for example, using different cultured cells and detection methods could fill the gap in the results of the cell traversal assays between Fig. 4A and Fernandes et al. (22), indicating that there was no statistical difference in cell wounding ability as detected by flow cytometry. RON2-cKD sporozoites also demonstrated reduced cell traversal ability, supporting that RON2 and RON4 function cooperatively through their interaction during migration and invasion. This is the first report to demonstrate the involvement of rhoptry proteins in attaching to and/or crossing the sinusoidal cell layer in vivo.

Microneme proteins are secreted from sporozoites during gliding and have been suggested to have a function in motility, such as TRAP, CSP, S4/Celtos, TRAP-related protein (S6/TREP/UOS3) (47 - 49), and LIMP (35). In contrast, it remained unclear how rhoptry proteins are involved in sporozoite attachment and motility. It was reported that RON4 is secreted during sporozoite infection of hepatocytes (23, 50). Furthermore, in Toxoplasma sporozoites, RON4 was detected at the moving junction during the invasion of cells (51). In this study, RON4 secretion was also detected during gliding (Fig. S8), suggesting that secreted RON4 mediates sporozoite attachment directly. In addition, we have demonstrated that anti-RON4 antibodies suppressed sporozoite infection of hepatocytes (Fig. 6 and Fig. S9). Taken together, our study indicated that RON4 secretes and functions during gliding and infection of hepatocytes. Further investigations might address if RON4 in sporozoites functions as a complex with AMA1, a known partner protein of the RON complex in merozoites.

In consideration of RON4 expression and its crucial roles both in Plasmodium sporozoites and merozoites, RON4 and other secreted rhoptry proteins might be new targets for the development of vaccines that could recognize both infectious stages in the Plasmodium life cycle. This possibility is supported by field-based reports suggesting that an anti-RON4 antibody titer is positively linked to malarial protection (52, 53).

It has been revealed that the rhoptry proteins RON4, RON2, RON5, and RON11 are crucial for sporozoite invasion via mediating attachment ability and motility (20, 21, 30). Further analyses on the secretion mechanism and interaction of these proteins, plus integration with the knowledge of micronemal proteins related to sporozoite gliding, will contribute to elucidate the comprehensive mechanisms of sporozoite infection.

ACKNOWLEDGMENTS

This work was supported by JSPS KAKENHI to T.I. (22H02859, 19H03459) and to M.B. (20K16235), and by AMED under Grant Number JP21wm0325039 to T.I. This study was supported by the Division of Analytical Bio-Medicine, the Advanced Research Support Center (ADRES), Ehime University.

We are grateful to Chris J. Janse, Leiden University, for supplying the Plasmodium berghei ANKA parasites expressing GFP under the control of the ef1a promoter. We thank Thomas J. Templeton for critical reading of the manuscript. We also thank A. Konishi and S. Sadaoka for rearing mice and technical support.

The authors declare no conflict of interest.

Contributor Information

Tomoko Ishino, Email: tishino.vip@tmd.ac.jp.

Laura A. Kirkman, Weill Cornell Medicine, New York, New York, USA

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/msphere.00587-22.

Figure S1. msphere.00587-22-s0001.tiff.

Generation of mCherry-tagged RON4 expressing transgenic parasites.

DOI: 10.1128/msphere.00587-22.SuF1
Figure S2. msphere.00587-22-s0002.tiff.

RON4 is not expressed during parasite development in hepatocytes.

DOI: 10.1128/msphere.00587-22.SuF2
Figure S3. msphere.00587-22-s0003.tif.

Western blot analysis of RON4 in salivary gland sporozoites.

DOI: 10.1128/msphere.00587-22.SuF3
Figure S4. msphere.00587-22-s0004.tiff.

RON4 is required for sporozoite infection of the liver.

DOI: 10.1128/msphere.00587-22.SuF4
Figure S5. msphere.00587-22-s0005.tiff.

Blood stage parasitemia after sporozoite injection.

DOI: 10.1128/msphere.00587-22.SuF5
Figure S6. msphere.00587-22-s0006.tiff.

RON4-cKD parasites develop normally after invasion of hepatocytes.

DOI: 10.1128/msphere.00587-22.SuF6
Figure S7. msphere.00587-22-s0007.tiff.

Number of gliding cycles.

DOI: 10.1128/msphere.00587-22.SuF7
Figure S8. msphere.00587-22-s0008.tif.

RON4 were detected at the tip of sporozoites without permeabilization.

DOI: 10.1128/msphere.00587-22.SuF8
Figure S9. msphere.00587-22-s0009.tiff.

Antibodies against RON4 inhibited sporozoite infection of hepatocytes in a dose-dependent manner.

DOI: 10.1128/msphere.00587-22.SuF9
TABLE S1. msphere.00587-22-s0010.pdf.

Table S1 and supplemental figure legends.

DOI: 10.1128/msphere.00587-22.SuF10

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. WHO . 2021. World malaria report.
  • 2. Langreth SG, Jensen JB, Reese RT, Trager W. 1978. Fine structure of human malaria in vitro. J Protozool 25:443–452. doi: 10.1111/j.1550-7408.1978.tb04167.x [DOI] [PubMed] [Google Scholar]
  • 3. Dubremetz JF, Torpier G. 1978. Freeze fracture study of the pellicle of an eimerian sporozoite (Protozoa, Coccidia). J Ultrastruct Res 62:94–109. doi: 10.1016/s0022-5320(78)90012-6 [DOI] [PubMed] [Google Scholar]
  • 4. Bradley PJ, Sibley LD. 2007. Rhoptries: an arsenal of secreted virulence factors. Curr Opin Microbiol 10:582–587. doi: 10.1016/j.mib.2007.09.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Besteiro S, Michelin A, Poncet J, Dubremetz J-F, Lebrun M. 2009. Export of a Toxoplasma gondii rhoptry neck protein complex at the host cell membrane to form the moving junction during invasion. PLoS Pathog 5: e1000309. doi: 10.1371/journal.ppat.1000309 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Alexander DL, Mital J, Ward GE, Bradley P, Boothroyd JC. 2005. Identification of the moving junction complex of Toxoplasma gondii: a collaboration between distinct secretory organelles. PLoS Pathog 1: e17. doi: 10.1371/journal.ppat.0010017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Cao J, Kaneko O, Thongkukiatkul A, Tachibana M, Otsuki H, Gao Q, Tsuboi T, Torii M. 2009. Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitol Int 58:29–35. doi: 10.1016/j.parint.2008.09.005 [DOI] [PubMed] [Google Scholar]
  • 8. Mutungi JK, Yahata K, Sakaguchi M, Kaneko O. 2014. Expression and localization of rhoptry neck protein 5 in merozoites and sporozoites of Plasmodium yoelii. Parasitol Int 63:794–801. doi: 10.1016/j.parint.2014.07.013 [DOI] [PubMed] [Google Scholar]
  • 9. Lebrun M, Michelin A, El Hajj H, Poncet J, Bradley PJ, Vial H, Dubremetz JF. 2005. The rhoptry neck protein RON4 re-localizes at the moving junction during Toxoplasma gondii invasion. Cell Microbiol 7:1823–1833. doi: 10.1111/j.1462-5822.2005.00646.x [DOI] [PubMed] [Google Scholar]
  • 10. Tonkin ML, Roques M, Lamarque MH, Pugnière M, Douguet D, Crawford J, Lebrun M, Boulanger MJ. 2011. Host cell invasion by apicomplexan parasites: insights from the co-structure of AMA1 with a RON2 peptide. Science 333:463–467. doi: 10.1126/science.1204988 [DOI] [PubMed] [Google Scholar]
  • 11. Vulliez-Le Normand B, Tonkin ML, Lamarque MH, Langer S, Hoos S, Roques M, Saul FA, Faber BW, Bentley GA, Boulanger MJ, Lebrun M. 2012. Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog 8: e1002755. doi: 10.1371/journal.ppat.1002755 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Srinivasan P, Beatty WL, Diouf A, Herrera R, Ambroggio X, Moch JK, Tyler JS, Narum DL, Pierce SK, Boothroyd JC, Haynes JD, Miller LH. 2011. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci U S A 108:13275–13280. doi: 10.1073/pnas.1110303108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Richard D, MacRaild CA, Riglar DT, Chan J-A, Foley M, Baum J, Ralph SA, Norton RS, Cowman AF. 2010. Interaction between Plasmodium falciparum apical membrane antigen 1 and the rhoptry neck protein complex defines a key step in the erythrocyte invasion process of malaria parasites. J Biol Chem 285:14815–14822. doi: 10.1074/jbc.M109.080770 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Bushell E, Gomes AR, Sanderson T, Anar B, Girling G, Herd C, Metcalf T, Modrzynska K, Schwach F, Martin RE, Mather MW, McFadden GI, Parts L, Rutledge GG, Vaidya AB, Wengelnik K, Rayner JC, Billker O. 2017. Functional profiling of a Plasmodium genome reveals an abundance of essential genes. Cell 170:260–272. doi: 10.1016/j.cell.2017.06.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Amino R, Thiberge S, Martin B, Celli S, Shorte S, Frischknecht F, Ménard R. 2006. Quantitative imaging of Plasmodium transmission from mosquito to mammal. Nat Med 12:220–224. doi: 10.1038/nm1350 [DOI] [PubMed] [Google Scholar]
  • 16. Amino R, Giovannini D, Thiberge S, Gueirard P, Boisson B, Dubremetz J-F, Prévost M-C, Ishino T, Yuda M, Ménard R. 2008. Host cell traversal is important for progression of the malaria parasite through the dermis to the liver. Cell Host Microbe 3:88–96. doi: 10.1016/j.chom.2007.12.007 [DOI] [PubMed] [Google Scholar]
  • 17. Tavares J, Formaglio P, Thiberge S, Mordelet E, Van Rooijen N, Medvinsky A, Ménard R, Amino R. 2013. Role of host cell traversal by the malaria sporozoite during liver infection. J Exp Med 210:905–915. doi: 10.1084/jem.20121130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Frischknecht F, Matuschewski K. 2017. Plasmodium sporozoite biology. Cold Spring Harb Perspect Med 7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Tokunaga N, Nozaki M, Tachibana M, Baba M, Matsuoka K, Tsuboi T, Torii M, Ishino T. 2019. Expression and localization profiles of rhoptry proteins in plasmodium berghei sporozoites. Front Cell Infect Microbiol 9:316. doi: 10.3389/fcimb.2019.00316 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Ishino T, Murata E, Tokunaga N, Baba M, Tachibana M, Thongkukiatkul A, Tsuboi T, Torii M. 2019. Rhoptry neck protein 2 expressed in Plasmodium sporozoites plays a crucial role during invasion of mosquito salivary glands. Cell Microbiol 21: e12964. doi: 10.1111/cmi.12964 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Nozaki M, Baba M, Tachibana M, Tokunaga N, Torii M, Ishino T. 2020. Detection of the rhoptry neck protein complex in Plasmodium sporozoites and its contribution to sporozoite invasion of salivary glands. mSphere 5: e00325-20. doi: 10.1128/mSphere.00325-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Fernandes P, Loubens M, Le Borgne R, Marinach C, Ardin B, Briquet S, Vincensini L, Hamada S, Hoareau-Coudert B, Verbavatz J-M, Weiner A, Silvie O. 2022. The ama1-ron complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. PLoS Pathog 18: e1010643. doi: 10.1371/journal.ppat.1010643 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Risco-Castillo V, Topçu S, Son O, Briquet S, Manzoni G, Silvie O. 2014. CD81 is required for rhoptry discharge during host cell invasion by plasmodium yoelii sporozoites. Cell Microbiol 16:1533–1548. doi: 10.1111/cmi.12309 [DOI] [PubMed] [Google Scholar]
  • 24. Giovannini D, Späth S, Lacroix C, Perazzi A, Bargieri D, Lagal V, Lebugle C, Combe A, Thiberge S, Baldacci P, Tardieux I, Ménard R. 2011. Independent roles of apical membrane antigen 1 and rhoptry neck proteins during host cell invasion by apicomplexa. Cell Host Microbe 10:591–602. doi: 10.1016/j.chom.2011.10.012 [DOI] [PubMed] [Google Scholar]
  • 25. Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, van der Linden R, Sinden RE, Waters AP, Janse CJ. 2004. A Plasmodium berghei reference line that constitutively expresses GFP at A high level throughout the complete life cycle. Mol Biochem Parasitol 137:23–33. doi: 10.1016/j.molbiopara.2004.04.007 [DOI] [PubMed] [Google Scholar]
  • 26. Janse CJ, Ramesar J, Waters AP. 2006. High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc 1:346–356. doi: 10.1038/nprot.2006.53 [DOI] [PubMed] [Google Scholar]
  • 27. Kennedy M, Fishbaugher ME, Vaughan AM, Patrapuvich R, Boonhok R, Yimamnuaychok N, Rezakhani N, Metzger P, Ponpuak M, Sattabongkot J, Kappe SH, Hume JCC, Lindner SE. 2012. A rapid and scalable density gradient purification method for Plasmodium sporozoites. Malar J 11: 421. doi: 10.1186/1475-2875-11-421 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. doi: 10.1093/nar/29.9.e45 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Ishino T, Yano K, Chinzei Y, Yuda M. 2004. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol 2: E4. doi: 10.1371/journal.pbio.0020004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Bantuchai S, Nozaki M, Thongkukiatkul A, Lorsuwannarat N, Tachibana M, Baba M, Matsuoka K, Tsuboi T, Torii M, Ishino T. 2019. Rhoptry neck protein 11 has crucial roles during malaria parasite sporozoite invasion of salivary glands and hepatocytes. Int J Parasitol 49:725–735. doi: 10.1016/j.ijpara.2019.05.001 [DOI] [PubMed] [Google Scholar]
  • 31. Ishino T, Chinzei Y, Yuda M. 2005. Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte. Mol Microbiol 58:1264–1275. doi: 10.1111/j.1365-2958.2005.04801.x [DOI] [PubMed] [Google Scholar]
  • 32. Sturm A, Amino R, van de Sand C, Regen T, Retzlaff S, Rennenberg A, Krueger A, Pollok J-M, Menard R, Heussler VT. 2006. Manipulation of host hepatocytes by the malaria parasite for delivery into liver sinusoids. Science 313:1287–1290. doi: 10.1126/science.1129720 [DOI] [PubMed] [Google Scholar]
  • 33. Yamauchi LM, Coppi A, Snounou G, Sinnis P. 2007. Plasmodium sporozoites trickle out of the injection site. Cell Microbiol 9:1215–1222. doi: 10.1111/j.1462-5822.2006.00861.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Mueller A-K, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, Kappe SHI. 2005. Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A 102:3022–3027. doi: 10.1073/pnas.0408442102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Santos JM, Egarter S, Zuzarte-Luís V, Kumar H, Moreau CA, Kehrer J, Pinto A, Costa M da, Franke-Fayard B, Janse CJ, Frischknecht F, Mair GR. 2017. Malaria parasite LIMP protein regulates sporozoite gliding motility and infectivity in mosquito and mammalian hosts. Elife 6: e24109. doi: 10.7554/eLife.24109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Sultan AA, Thathy V, Frevert U, Robson KJ, Crisanti A, Nussenzweig V, Nussenzweig RS, Ménard R. 1997. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell 90:511–522. doi: 10.1016/s0092-8674(00)80511-5 [DOI] [PubMed] [Google Scholar]
  • 37. Beyer K, Kracht S, Kehrer J, Singer M, Klug D, Frischknecht F. 2021. Limited Plasmodium sporozoite gliding motility in the absence of TRAP family adhesins. Malar J 20:430. doi: 10.1186/s12936-021-03960-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Frénal K, Dubremetz J-F, Lebrun M, Soldati-Favre D. 2017. Gliding motility powers invasion and egress in Apicomplexa. Nat Rev Microbiol 15:645–660. doi: 10.1038/nrmicro.2017.86 [DOI] [PubMed] [Google Scholar]
  • 39. Münter S, Sabass B, Selhuber-Unkel C, Kudryashev M, Hegge S, Engel U, Spatz JP, Matuschewski K, Schwarz US, Frischknecht F. 2009. Plasmodium sporozoite motility is modulated by the turnover of discrete adhesion sites. Cell Host Microbe 6:551–562. doi: 10.1016/j.chom.2009.11.007 [DOI] [PubMed] [Google Scholar]
  • 40. Montagna GN, Matuschewski K, Buscaglia CA. 2012. Plasmodium sporozoite motility: an update. Front Biosci (Landmark Ed) 17:726–744. doi: 10.2741/3954 [DOI] [PubMed] [Google Scholar]
  • 41. Sultan AA. 1999. Molecular mechanisms of malaria sporozoite motility and invasion of host cells. Int Microbiol 2:155–160. [PubMed] [Google Scholar]
  • 42. Ménard R. 2001. Gliding motility and cell invasion by Apicomplexa: insights from the Plasmodium sporozoite. Cell Microbiol 3:63–73. doi: 10.1046/j.1462-5822.2001.00097.x [DOI] [PubMed] [Google Scholar]
  • 43. Moreira CK, Templeton TJ, Lavazec C, Hayward RE, Hobbs CV, Kroeze H, Janse CJ, Waters AP, Sinnis P, Coppi A. 2008. The Plasmodium TRAP/MIC2 family member, TRAP-Like protein (TLP), is involved in tissue traversal by sporozoites. Cell Microbiol 10:1505–1516. doi: 10.1111/j.1462-5822.2008.01143.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Lopaticki S, Yang ASP, John A, Scott NE, Lingford JP, O’Neill MT, Erickson SM, McKenzie NC, Jennison C, Whitehead LW, Douglas DN, Kneteman NM, Goddard-Borger ED, Boddey JA. 2017. Protein O-fucosylation in Plasmodium falciparum ensures efficient infection of mosquito and vertebrate hosts. Nat Commun 8:561. doi: 10.1038/s41467-017-00571-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Steel RWJ, Pei Y, Camargo N, Kaushansky A, Dankwa DA, Martinson T, Nguyen T, Betz W, Cardamone H, Vigdorovich V, Dambrauskas N, Carbonetti S, Vaughan AM, Sather DN, Kappe SHI. 2018. Plasmodium yoelii S4/CelTOS is important for sporozoite gliding motility and cell traversal. Cell Microbiol 20: e12817. doi: 10.1111/cmi.12817 [DOI] [PubMed] [Google Scholar]
  • 46. Kariu T, Ishino T, Yano K, Chinzei Y, Yuda M. 2006. CelTOS, a novel malarial protein that mediates transmission to mosquito and vertebrate hosts. Mol Microbiol 59:1369–1379. doi: 10.1111/j.1365-2958.2005.05024.x [DOI] [PubMed] [Google Scholar]
  • 47. Mikolajczak SA, Silva-Rivera H, Peng X, Tarun AS, Camargo N, Jacobs-Lorena V, Daly TM, Bergman LW, de la Vega P, Williams J, Aly ASI, Kappe SHI. 2008. Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host. Mol Cell Biol 28:6196–6207. doi: 10.1128/MCB.00553-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Steinbuechel M, Matuschewski K. 2009. Role for the Plasmodium sporozoite-specific transmembrane protein S6 in parasite motility and efficient malaria transmission. Cell Microbiol 11:279–288. doi: 10.1111/j.1462-5822.2008.01252.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Combe A, Moreira C, Ackerman S, Thiberge S, Templeton TJ, Ménard R. 2009. TREP, a novel protein necessary for gliding motility of the malaria sporozoite. Int J Parasitol 39:489–496. doi: 10.1016/j.ijpara.2008.10.004 [DOI] [PubMed] [Google Scholar]
  • 50. Yang ASP, Lopaticki S, O’Neill MT, Erickson SM, Douglas DN, Kneteman NM, Boddey JA. 2017. Ama1 and MAEBL are important for Plasmodium falciparum sporozoite infection of the liver. Cell Microbiol 19. doi: 10.1111/cmi.12745 [DOI] [PubMed] [Google Scholar]
  • 51. Tartarelli I, Tinari A, Possenti A, Cherchi S, Falchi M, Dubey JP, Spano F. 2020. During host cell traversal and cell-to-cell passage, Toxoplasma gondii sporozoites inhabit the parasitophorous vacuole and posteriorly release dense granule protein-associated membranous trails. Int J Parasitol 50:1099–1115. doi: 10.1016/j.ijpara.2020.06.012 [DOI] [PubMed] [Google Scholar]
  • 52. Richards JS, Arumugam TU, Reiling L, Healer J, Hodder AN, Fowkes FJI, Cross N, Langer C, Takeo S, Uboldi AD, Thompson JK, Gilson PR, Coppel RL, Siba PM, King CL, Torii M, Chitnis CE, Narum DL, Mueller I, Crabb BS, Cowman AF, Tsuboi T, Beeson JG. 2013. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J Immunol 191:795–809. doi: 10.4049/jimmunol.1300778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Kanoi BN, Takashima E, Morita M, White MT, Palacpac NMQ, Ntege EH, Balikagala B, Yeka A, Egwang TG, Horii T, Tsuboi T. 2017. Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda. Vaccine 35:873–881. doi: 10.1016/j.vaccine.2017.01.001 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figure S1. msphere.00587-22-s0001.tiff.

Generation of mCherry-tagged RON4 expressing transgenic parasites.

DOI: 10.1128/msphere.00587-22.SuF1
Figure S2. msphere.00587-22-s0002.tiff.

RON4 is not expressed during parasite development in hepatocytes.

DOI: 10.1128/msphere.00587-22.SuF2
Figure S3. msphere.00587-22-s0003.tif.

Western blot analysis of RON4 in salivary gland sporozoites.

DOI: 10.1128/msphere.00587-22.SuF3
Figure S4. msphere.00587-22-s0004.tiff.

RON4 is required for sporozoite infection of the liver.

DOI: 10.1128/msphere.00587-22.SuF4
Figure S5. msphere.00587-22-s0005.tiff.

Blood stage parasitemia after sporozoite injection.

DOI: 10.1128/msphere.00587-22.SuF5
Figure S6. msphere.00587-22-s0006.tiff.

RON4-cKD parasites develop normally after invasion of hepatocytes.

DOI: 10.1128/msphere.00587-22.SuF6
Figure S7. msphere.00587-22-s0007.tiff.

Number of gliding cycles.

DOI: 10.1128/msphere.00587-22.SuF7
Figure S8. msphere.00587-22-s0008.tif.

RON4 were detected at the tip of sporozoites without permeabilization.

DOI: 10.1128/msphere.00587-22.SuF8
Figure S9. msphere.00587-22-s0009.tiff.

Antibodies against RON4 inhibited sporozoite infection of hepatocytes in a dose-dependent manner.

DOI: 10.1128/msphere.00587-22.SuF9
TABLE S1. msphere.00587-22-s0010.pdf.

Table S1 and supplemental figure legends.

DOI: 10.1128/msphere.00587-22.SuF10

Articles from mSphere are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES